Wednesday, February 27, 2013

Dna Online Database Lab Report

Worksheet: Searching online database.
PubMed
1. Maslinic acid [MA] is an inhibitor of glycogen phosphorylase. This study was done to engineer the effects of MA on noetic ischemia [restriction in blood supply] in hyperglycemic rats to draw out multiple biological activities. Hyperglycemic rats were made by injecting streptozotocin [natural chemical that induces type I diabetes]. diabetic rats treated with high-dose of MA had lower blood glucose level. Conclusively, MA showed anti-diabetic wont in rats and direct beneficiary effect in cerebral ischemic injury by promoting glutamate clearance by GLT-1 regulation.
2. diary: Diabetes.2005 Aug: 54(8):2453-9
Glycogen phosphorylase degrades glycogen in animals by releasing glucose-1-phosphate. This dish out mostly occurs in liver, thus inhibition of hepatic glycogen phosphorylase can prevent hyperglycemia in type II diabetes [diabetes mellitus]. At the same time glycogen phosphorylase activity is fundamental for muscle functioning too. Thus inhibiting this enzyme might fatigue the muscle by lactate production during muscle contraction.
3. Molecule : GT1-glycogen-phosphorylase
PDB ID: 3T3I
4. Tar positioning AKT protein kinase in gastric cancer. Almhanna K, Strosberg J and Malafa M. Anticancer Res. 2011 Dec; 31(12): 4387-92.

BLAST hard-hitting
5. Similarity of bovid insulin scope A to human insulin chain A.

Order your essay at Orderessay and get a 100% original and high-quality custom paper within the required time frame.


Query 1 GIVEQCCASVCSLYQLENYCN 21
GIVEQCC S+CSLYQLENYCN
Sbjct 2 GIVEQCCTSICSLYQLENYCN 22
1 convertible residue
1 non- like residue
Rests are identical

6. Similarity of A chain of bovine insulin to tuna:
GIVEQCCASVCSLYQLENYCN 21
GIVEQCC C + L +NYCN
GIVEQCCHKPCNIFDLQNYCN 51
6 non-similar
2 similar residues and rests are identical between two proteases....If you want to get a full essay, order it on our website: Orderessay



If you want to get a full essay, wisit our page: write my essay .

No comments:

Post a Comment